#

Vazhnoe

: 691
Traditional safe-haven assets are becoming less effective at protecting investors from AI risks / Photo: Margarita Young/Shutterstock.com
News·
Dividends, Gold, ETFs: Wall Street Outlines 5 Steps to Protect Your Portfolio from AI Risks
Following Tesla and Metas earnings reports, investors are once again assessing the cost of AI / Photo: X/NYSE
News·
Another sell-off in tech stocks: Meta and Tesla failed to calm the market
All servers running any version of PHP released in the past 20 years are potentially vulnerable / Photo: Salaf.arif / Shutterstock.com
News·
Millions of Hacking Attempts: 5 Questions About a Critical Network Vulnerability Discovered by AI
The AI assistant Muse AI reached 10 million downloads in just 40 days after its launch, surpassing ChatGPT and Claude / Photo: Erlin Diah / Shutterstock.com
News·
"The Music's Still Playing": What Wall Street Recommends Doing with Meta Shares Ahead of the Earnings Report
Quite a few eggs in one ambitious basket: What analysts are saying about the Tesla-SpaceX merger
News·
"Quite a few eggs in one ambitious basket": What analysts are saying about the Tesla-SpaceX merger
Streaming giant Netflix will release its third-quarter 2026 earnings report on October 20 / Photo: Wirestock Creators/Shutterstock.com
News·
Netflix shares have fallen by a quarter since the start of the year. Should you buy them before the earnings report?
Elices disastrous debut following its IPO in Seoul has heightened doubts about the wisdom of massive investments in AI / Photo: Shutterstock.com
News·
Shares of the AI startup Elice plummeted 32% after its IPO. Why is this a bad sign for the market?
Photo: X / NYSE
News·
"A buying opportunity is emerging": Nasdaq jumped 1% after the sell-off
The market resembles a brewing super volcano, Burry argues, with conditions appearing stable on the surface but imbalances brewing underneath / Photo: Shutterstock
News·
Burry likens next market crash to a super volcano and offers five signs for investors
Tesla will release its quarterly report on October 21 / Photo: X/Tesla
News·
Tesla and Meta Earnings Reports, PMI Data in the U.S. and Europe: What Investors Can Expect This Week
The company is developing RNAi-based drugs to treat thromboembolic diseases and Stargardt disease, with its lead product in early-stage trials / Photo: City Therapeutics
Small Caps·
City Therapeutics IPO: Developer of RNAi-based drugs debuts on the Nasdaq
Rising public debt in the worlds largest economies and increased borrowing by hyperscalers are fueling investor concerns. Photo: Chenyu Guan / Unsplash.com
Review·
Where to Invest $10,000 to Gain Protection and Income in a Bear Market for Bonds
Load more